AncaSt retweeted
1/10
#NephJC #TenPostNephJC.
#NephTwitter
Patient outcomes are better with transplant vs dialysis.
Is this always true?
What about high-risk donors (expanded criteria donor-ECD) or recipients (elderly with DM or CVD)?
Read the article 👇
link to article on pubmed.ncbi.nlm.nih.gov/4275…
Check-out the latest NephJC blog #Nephtwitter
🚨This week we are looking at a target trial emulation on transplantation.
Do older pts benefit from kidney transplant?
What if donation is after: CV death or brain death?
What if donor is a standard (SCD) or extended (ECD) criteria donor? #NephTwitter
nephjc.com/news/transplantem…
⚠️🆙
1/ 🧵Tweetorial Alert 🧵Hey, #NephTwitter
Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports
AncaSt retweeted
Hey #NephJC 👋
Checkout the VA by @DivyaveerSSNeph
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start but hard to stop.
#NephTwitter
nephjc.com/news/starttrial
❤️
Steroids are useful (and have bad side effects) in patients with podocytopathies.
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢#NephTwitter #NephJC
nephjc.com/news/startsteroid…
Check out the new e-seminar!
💹Counseling and management of pregnancy in kidney transplant recipients
An important part of any nephrologist practice is the holistic approach of our patients. This e-seminar covers matters of counselling and how to manage pregnant kidney transplant patients.
Speaker: @licia_peruzzi, @gb_piccoli
Panellist: Annelies de Weerd
Moderator: @Ilagandolf
Hmmm, what else can we talk about in anti-GBM disease? Check-out the e-seminar 🔥
What`s old and new with anti-glomerular basement membrane (anti-GBM) disease?🔥 And what are the problems in diagnosing and treating anti-GBM disease – more answers in this 🏹e-seminar:
Speaker: Alan Salama
Moderator: @AnnetteBruchfe1
Panellists: Federica Mescia, Marten Segelmark
✨
1/10
#NephJC #TenPostNephJC
Validation of an AI model is difficult. 🤖
Enter the REFINe trial (Reasoning Enhancement With Feedback From a Generative AI in Nephrology), a RCT of large language model (LLM) -assisted diagnostic accuracy in nephrology.
kireports.org/article/S2468-…
🤖🤖🤖
🤖AI is everywhere 🤖 (you will be assimilated!)
Can the current LLMs help nephrologist diagnose complex nephrology cases?
Right out of Sci-Fi movie, it is the REFINe study.
VA by @kiddo_kidney
#NephTwitter #NephJC
nephjc.com/news/refine-the-v…
Very very proud to share this ✨ first, but not last.
@kiddo_kidney, thank you for being a great teammate ✨ and always happy to learn with @NephJC experts who made this a great experience
To BIC or not to BIC?
This week we're talkin about IV Sodium Bicarbonate in the ICU.
💉Does it improve mortality, MAKE30... or just pH?
🥤The SODa-BIC study
#NephTwitter #MedTwitter
nephjc.com/news/soda-bic
Check this out - should we cut back on bicarb im critically ill patients?
Shout-out to @danyrcal for this amazing VA ✨
🖌️Check out the #visualabstract for the SODa-BIC trial by @danyrcal
#NephJC
nephjc.com/news/2026/8/3/sod…
Amazing read from @NephJC
👀Seek and you shall FIND 🔎
#ERA26 #NephTwitter
FIND-CKD asks if finerenone is beneficial in patients with non-diabetic CKD.
Blog by @ManoleaA & @DivyaveerSSNeph
nephjc.com/news/2026/7/6/fin…
Great first year at #ERA26 SOME team for me ❣️
Another amazing encounter at #ERA26
What a great time to be a nephrologist ✨❤️
#finerenone #findCKD @dianarodespi @VladoPerkovic
Being in #latebreakingclinicaltrials at #ERA26 feels like a Taylor Swift concert. Loving every second ❤️✨ #finerenone #findCKD #obinutuzumab #rituximabinnephroticGN #aHUS
Amazing session - especially with @lumivoro13 there ✨
#ERA26
Matters of the heart continues with.... Well: Matters of the heart: cardio‑renal outcomes✨❤️
Speaker 🗣️: @lumivoro13
